In this episode, Kate wraps up the end of this mini-series with Kerry Lummus. 
They discuss insights gained from the series so far and leave listeners with key takeaways of what to consider when bringing new products into the healthcare market.

As a change from the norm this episode with Gail Jackson, CEO of Solving Kids’ Cancer, brings a challenge to our listeners. 
As innovators and fresh thinkers, what ideas do you have to overcome research challenges in childhood cancer treatments?
Did you know that in 2022 only £80,000 was paid by the central government for neuroblastoma research?
How can we find better, less toxic treatments for children when funding and regulation work against us?
Calling all innovators, listen to this podcast and start thinking about how things can be changed. https://www.solvingkidscancer.org.uk

Jill is a Chartered Accountant and owner of EBS Chartered Accountants.  
In this episode, Jill discussed some important steps for a new business, such as when/whether to register as a limited company, the pros and cons of VAT registration, and R&D tax credits.  
Creating new products in MedTech isn’t just about the technology, you have a business to run too!

Chris is a Recruitment Operations Manager at Evolve and specialises in recruiting sales staff for MedTech and pharmaceutical companies.  
He has worked with many companies when they first brought their products to market and discusses the pros and cons of distributors, headcount, and outsourced sales teams. Find out when to start thinking and preparing for recruitment to sell your product to a wider audience, how much it will cost, and how long you must be prepared to wait to get results.

Dr Desai is a Consultant Gastroenterologist and Director of Eureka Inventions Limited. 
Eureka focuses on patient safety, and their first product has been developed to prevent the retention of swabs during surgery. 
Dr Desai and his wife, also an NHS Consultant, have successfully navigated the innovation support structure for UK Health Innovation to get the right help, advice, and funding.  
Hear about their journey and how they balance their business with clinical practice.

Alex is the Deputy Director of Health Innovation West of England (previously known as West of England Academic Health Science Network (AHSN)). 
Alex and I discuss the change from AHSN to Health Innovation Organisation, part of the 15-strong network of Innovation organisations that cover the UK in the Health Innovation Network. 
The help and support offered to innovators includes networking and introductions, support with implementation and funding. 
The Innovation Network can be contacted through the NHS Innovation Service portal www.innovation.nhs.uk

Do you need a clinical trial? 
Nicola and Elizabeth are co-founders and directors of Afortiori Developments, a Contract Research Organisation (CRO), that has worked with companies of all sizes but is particularly familiar with SMEs and new market entrants.  
We discuss what needs to be considered when planning a clinical trial, which units and clinicians to work with, and the differing levels of evidence that may be required.  

In a break from the norm, this episode is a discussion between Kate and mother and son, Laura, and Elias.  
We discuss ADHD, podcasts, dementia, and how to go about creating effective technology.  Also, what happens when your great idea doesn’t quite make it?  
Talking from the perspective of the problem rather than the solution.  

Vicki Munro is a very experienced Health Economist and Senior Associate at Pym’s Consultancy.  
We discuss the role of Health Economics in bringing a new product to market and the vital part Health Economics plays in NICE Approval.  
Thought passing regulatory hurdles was enough? Think again, what does your Cost Per QALY look like?

The Chief Executive of Gain (Guillan Barré and Associated Neuropathies), a national charity, discusses the reality of being a patient living with a neurological condition, and how the charity works with companies trying to improve patient lives. 

In previous episodes, we have discussed the importance of patient and public involvement. In this episode, you find out what is involved.